Evaluation of mathematical models describing drug release from estradiol transdermal systems

Drug Development and Industrial Pharmacy

Volumn 29, Issue 1, 2003, Pages 89-97

  Costa, P ^a   Sousa Lobo, J M ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Drug release; Estradiol; Kinetic models; Transdermal systems

Indexed keywords

ESTRADIOL;

ARTICLE; DRUG ABSORPTION; DRUG DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MATHEMATICAL MODEL; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; ESTRADIOL; KINETICS; MODELS, CHEMICAL; SOLUBILITY;

EID: 0037273037     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120016687     Document Type: Article

References (23)

1. Nicoli, S.; Santi, P. New approaches of transdermal delivery. Eur. Pharm. Rev. 2001, 1 (1), 59-63.
2. Costa, P.; Sousa Lobo, J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13 (2), 123-133.
3. Donbrow, M.; Samuelov, Y. Zero order drug delivery from double-layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures. J. Pharm. Pharmacol. 1980, 32 (7), 463-470.
4. Varelas, C.G.; Dixon, D.G.; Carol, S. Zero-order release from biphasic polymer hydrogels. J. Contr. Rel. 1995, 34 (2), 185-192.
5. Gibaldi, M.; Feldman, S. Establishment of sink conditions in dissolution rate determinations -theoretical considerations and application to nondisintegrating dosage forms. J. Pharm. Sci. 1967, 56 (10), 1238-1242.
6. Wagner, J.G. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 1969, 58 (10), 1253-1257.
7. Higuchi, T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50 (10), 874-875.
8. Higuchi, T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52 (12), 1145-1149.
9. Cobby, J.; Mayersohn, M.; Walker, G.C. Influence of shape factors on kinetics of drug release from matrix tablets II: Experimental. J. Pharm. Sci. 1974, 63 (5), 732-737.
10. Langenbucher, F. Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmac. 1972, 24 (12), 979-981.
11. Goldsmith, J.A.; Randall, N.; Ross, S.D. On methods of expressing dissolution rate data. J. Pharm. Pharmac. 1978, 30 (6), 347-349.
12. Romero, P.; Costa, J.B.; Castel-Maroteaux Chulia, D. Statistical optimization of a controlled release formulation obtained by a double compression process: application of a hadamard matrix and a factorial design. In Pharmaceutical Technology, Controlled Drug Release; Wells J.I., Rubinstein, M.H., Eds.; Ellis Horwood: New York, 1991; Vol. 2, 44-58.
13. Vudathala, G.K.; Rogers, J.A. Dissolution of fludrocortisone from phospholipid coprecipitates. J. Pharm. Sci. 1992, 81 (3), 282-286.
14. Korsmeyer, R.W.; Peppas, N.A. Macromolecular and modeling aspects of swelling-controlled systems. In Controlled Release Delivery Systems; Roseman, T.J., Mansdorf, S.Z., Eds.; Marcel Dekker, Inc: New York and Basel, 1981; 77-90.
15. Korsmeyer, R.W.; Gurny, R.; Doelker, E.M.; Buri, P.; Peppas, N.A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15 (1), 25-35.
16. Peppas, N.A. Analysis of fickian and nonFickian drug release from polymers. Pharm. Acta. Helv. 1985, 60 (4), 110-111.
17. Harland, R.S.; Gazzaniga, A.; Sangalli, M.E.; Colombo, P.; Peppas, N.A. Drug/polymer matrix swelling and dissolution. Pharm. Res. 1988, 5 (8), 488-494.
18. Kim, H.; Fassihi, R. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci. 1997, 86 (3), 323-328.
19. Pais, J. Intuiting mathematical objects using diagrams and kinetigrams. Journal of online mathematics and its applications (JOMA) 2001, 1 (2). http://www.bham.ac.uk/ctimath/talum/newsletter/pais.htm (accessed May 2002).
20. Estradiol tablets. United States Pharmacopoeia 23/National Formulary 18. U.S. Pharmacopeial Convention: Rockville, 1995; 624.
21. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Validation of analytical procedures: Definitions and Terminology, ICH Harmonised Tripartite Guidelines, Q2A, 1995 (CPMP/ICH/381/95).
22. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, Validation of analytical procedures: methodology, ICH harmonised tripartite guidelines, Q2B, 1996, (CPMP/ICH/281/95).
23. Tymes, N.W.; Shah, V.P.; Skelly, J.P. In vitro release profile of estradiol transdermal therapeutic systems. J. Pharm. Sci. 1990, 79 (7), 601-602.